[PDF][PDF] Progress report on the Nordic diltiazem study (NORDIL): an outcome study in hypertensive patients
T HEDNER - Blood pressure, 1999 - Taylor & Francis
The benefits of antihypertensive drug therapy have been documented in a large number of
intervention trials [1]. The relative benefit of lowering the diastolic blood pressure by 5–6 …
intervention trials [1]. The relative benefit of lowering the diastolic blood pressure by 5–6 …
Calcium Antagonist Antihypertensive Treatment of Non-Insulin-Dependent Diabetics: Efficacy and Safety of Lacidipine Versus Nifedipine SR
M Gulizia, R Valenti, F Platania… - Journal of …, 1994 - journals.lww.com
Arterial hypertension is a chronic condition regarded as one of the main risk factors for
development of coronary atherosclerosis. As dyslipidemia and reduced glucose tolerance …
development of coronary atherosclerosis. As dyslipidemia and reduced glucose tolerance …
[HTML][HTML] Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly …
T Ogihara, T Saruta, H Rakugi, K Shimamoto… - Hypertension …, 2009 - nature.com
The COLM study is an investigator-initiated trial comparing the combination therapy using
an angiotensin II receptor blocker (ARB), olmesartan, and a calcium channel blocker (CCB) …
an angiotensin II receptor blocker (ARB), olmesartan, and a calcium channel blocker (CCB) …
Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP‐Hypertension‐2
T Ekbom, E Linjer, T Hedner, J Lanke, U De Faire… - Blood …, 2004 - Taylor & Francis
Objective: To perform a subgroup analysis on those patients in STOP‐Hypertension‐2 who
had isolated systolic hypertension. Design and methods: The STOP‐Hypertension‐2 study …
had isolated systolic hypertension. Design and methods: The STOP‐Hypertension‐2 study …
Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial
JA Staessen, L Thijs, J Gąsowski, RH Fagard… - The American journal of …, 1998 - Elsevier
The Systolic Hypertension in Europe (Syst-Eur) study investigated whether antihypertensive
treatment could decrease the risk of cardiovascular complications in elderly patients with …
treatment could decrease the risk of cardiovascular complications in elderly patients with …
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the …
FHH Leenen, CE Nwachuku, HR Black… - …, 2006 - Am Heart Assoc
The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)
provides a unique opportunity to compare the long-term relative safety and efficacy of …
provides a unique opportunity to compare the long-term relative safety and efficacy of …
Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension
G Leonetti - Journal of cardiovascular pharmacology, 1991 - journals.lww.com
Lacidipine is a calcium antagonist of the dihydropyridine group that is highly selective for
vascular tissues. It has been tested during the last few years for the treatment of arterial …
vascular tissues. It has been tested during the last few years for the treatment of arterial …
Efficacy and acceptability of lercanidipine are not age dependent in patients with essential hypertension: the AGATE study
P Poncelet, J Ribstein, L Goullard… - … de Cardiologie et d' …, 2004 - europepmc.org
Methods Two groups of hypertensive patients (G1: aged< 65, G2: aged> or= 65) entered an
open study conducted over 56 days. All received lercanidipine 10 mg/d (monotherapy or …
open study conducted over 56 days. All received lercanidipine 10 mg/d (monotherapy or …
STONE study and INSIGHT study: efficacy of nifedipine in the prevention of cardiovascular disease in hypertensive patients.
H Matsuoka - Drugs, 2006 - search.ebscohost.com
Abstract Treatment with antihypertensive drugs improves prognosis in patients with
hypertension. The single-blind STONE (Shanghai Trial of Nifedipine in the Elderly) study …
hypertension. The single-blind STONE (Shanghai Trial of Nifedipine in the Elderly) study …